M&A Deal Summary |
|
---|---|
Date | 2022-05-17 |
Target | BioCentriq |
Sector | Life Science |
Buyer(s) | Green Cross |
Sellers(s) | NJII |
Deal Type | Divestiture |
Deal Value | 73M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1967 |
Sector | Life Science |
Employees | 150 |
Revenue | 2.06T KRW (2023) |
Green Cross is a holding company, which operates pharmaceuticals, biotechnology, distribution system, life insurance, and healthcare providers' total healthcare solutions that address the evolving needs of human health. Green Cross was founded in 1967 and is based in Yongin, South Korea.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (New Jersey) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
NJII helps turn ideas into workable solutions across four divisions: healthcare, entrepreneurship, defense, homeland security, and professional and corporate education. NJII was founded in 2014 and is headquartered in Newark, New Jersey.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (New Jersey) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 1 of 1 |